Volumetric reductions in the hippocampus and medial prefrontal cortex (mPFC) are among
the most well-documented neural abnormalities in major depressive disorder (MDD) …

Introduction Major depressive disorder (MDD) is a global psychiatric disorder with no
established biomarker. There is growing evidence that functional near-infrared spectroscopy …

Reduced haemodynamic response in the frontotemporal cortices of patients with major
depressive disorder (MDD) has been demonstrated using functional near-infrared …

The pattern of structural brain alterations associated with major depressive disorder (MDD)
remains unresolved. This is in part due to small sample sizes of neuroimaging studies …

Many psychiatric disorders, despite their specific characteristics, share deficits in the
cognitive domain including executive functions, emotional control and memory. However …

Finding robust brain substrates of mood disorders is an important target for research. The
degree to which major depression (MDD) and bipolar disorder (BD) are associated with …

Youth (including both childhood and adolescence) is a period when the brain undergoes
dramatic remodeling and is also a time when neuropsychiatric conditions often emerge …

Background Neuroimaging studies have consistently reported similar brain structural
abnormalities across different psychiatric disorders. Yet, the extent and regional distribution …

Depression is a syndrome of stress-and emotion-dysregulation, involving compromised
structural integrity of frontal-limbic networks. Meta-analytic evidence indicates that volumetric …

The neuro-anatomical substrates of major depressive disorder (MDD) are still not well
understood, despite many neuroimaging studies over the past few decades. Here we …